Organic Vaccines is a biotech in the final stage of development of a patented, personalized, DNA vaccine that uses an individual’s own cells.
This new flu vaccine addresses the pain points in an underserved flu market.
With a renowned Scientific Advisory Board, including a Nobel Prize recipient and partners such as Sloan Kettering in NY and Inserm in Paris
we are doing the first-in-man this year, and a Phase III clinical trial within 12 months.
The company and its patent portfolio will be sold to a pharma looking for new IP and who will have the capacity to bring the service to market.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://NA
- Keywords
- Personalized DNA Vaccine.
- Competitors
- Longevity Biotech Fellowship, NIZHPHARM Group.
Organic Vaccines Questions
Organic Vaccines's website is http://NA
Organic Vaccines's LinkedIn profile is https://www.linkedin.com/company/organic-vaccines
Organic Vaccines has
1 employees.
View email and phone details for 1
employees at Organic Vaccines.
Organic Vaccines's industry is
Biotechnology Research
Organic Vaccines's top competitors are
Longevity Biotech Fellowship,
Nizhpharm Group.
Organic Vaccines's categories are Biotechnology Research
Organic Vaccines's founding year is 2010
